Home › Funds › MPM BioImpact LLC › HOWL
MPM BioImpact LLC position in HOWL
WEREWOLF THERAPEUTICS INC · Health Care
MPM BioImpact LLC reported holding 80,142 shares of HOWL (WEREWOLF THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$29K, representing 0.00% of its reported portfolio and ranking #37 among its reported holdings. MPM BioImpact LLC has disclosed HOWL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's HOWL position evolved
MPM BioImpact LLC first disclosed a stake in HOWL in Q3 2023 at 2,388,011 shares (US$5.1M). The position peaked in Q1 2024 at 2,388,011 shares, worth US$15.5M. Across 12 filings, MPM BioImpact LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 80,142 shares valued at US$29K — a reduction of -1,128,668 shares quarter over quarter.. Notable position changes include a 42% trim in Q4 2025 (shares rose 31% over the following quarter), a 93% trim in Q2 2026 (shares rose 156% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.39M | $5.11M | New |
| Q4 2023 | 2.39M | $9.22M | Hold |
| Q1 2024 | 2.39M | $15.47M | Hold |
| Q2 2024 | 2.39M | $5.83M | Hold |
| Q3 2024 | 2.39M | $5.06M | Hold |
| Q4 2024 | 2.39M | $3.53M | Hold |
| Q1 2025 | 2.41M | $2.34M | Add |
| Q2 2025 | 2.41M | $2.63M | Hold |
| Q3 2025 | 2.41M | $4.75M | Hold |
| Q4 2025 | 1.39M | $883.51K | Reduce |
| Q1 2026 | 1.21M | $1.01M | Reduce |
| Q2 2026 | 80.14K | $28.85K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HOWL and 13F data
HOWL (WEREWOLF THERAPEUTICS INC) is a Health Care company. 15 other funds we track also report a position in HOWL — the largest reported positions include DC Funds, LP (US$212.0M), Lynx1 Capital Management LP (US$237K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HOWL
- DC Funds, LP 589.10K sh · $212.02M · Q2 2026
- Lynx1 Capital Management LP 657.79K sh · $236.74K · Q2 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held HOWL?
MPM BioImpact LLC has disclosed HOWL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is MPM BioImpact LLC's current position in HOWL?
As of Q2 2026, MPM BioImpact LLC holds 80.14K shares of HOWL (WEREWOLF THERAPEUTICS INC), valued at $28.85K, representing 0.00% of its reported portfolio and ranking #37.
Has MPM BioImpact LLC been buying or selling HOWL?
In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in HOWL. The position peaked in Q1 2024 at 2.39M shares.
Which other funds hold HOWL?
Other major institutional holders of HOWL include DC Funds, LP, Lynx1 Capital Management LP, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.